Helicure AB develops vaccines to protect against gastric cancer and ulcer disease, caused by Helicobacter pylori.
Oral or nasal vaccines will be created using proprietary attachment proteins from Helicobacter pylori as immunization agents, combined with immune stimulating adjuvants.
